🇺🇸 FDA
Pipeline program

EXS74539

EXS74539-002

Phase 1 small_molecule active

Quick answer

EXS74539 for Solid Tumor is a Phase 1 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
RECURSION PHARMACEUTICALS, INC.
Indication
Solid Tumor
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials